ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,367Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 252

$823K Total Retail Price of All Prescriptions

Rank: 27 out of 252

482 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

27% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 12,779 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 758 450 S3 1 5
FUROSEMIDE 641 525 2 7
PRAVASTATIN SODIUM 493 421 3 12
POTASSIUM CHLORIDE 446 366 4 8
AMLODIPINE BESYLATE 424 342 5 4
OMEPRAZOLE 421 302 6 6
ATORVASTATIN CALCIUM 395 320 7 16
LISINOPRIL 394 346 8 3
LEVOTHYROXINE SODIUM 314 289 9 1
METFORMIN HCL 309 232 10 9
GLIMEPIRIDE 303 250 11 40
DONEPEZIL HCL 288 265 12 28
NAMENDA 271 248 13 41
METOPROLOL TARTRATE 259 226 14 10
SULFAMETHOXAZOLE-TRIMETHOPRIM 247 176 15 87
METOPROLOL SUCCINATE 242 167 16 19
GABAPENTIN 230 184 17 11
SIMVASTATIN 224 173 18 2
AMLODIPINE BESYLATE-BENAZEPRIL 224 165 18 60
ALLOPURINOL 219 198 20 30
CLOPIDOGREL 209 166 21 29
CARVEDILOL 200 176 22 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 141 23 25
DOXYCYCLINE HYCLATE 181 119 23 92
TRAMADOL HCL 179 141 25 17
CITALOPRAM HBR 171 145 26 15
PLAVIX 170 126 27 43
WARFARIN SODIUM 167 151 28 14
KLOR-CON 10 136 117 29 146
ENALAPRIL MALEATE 133 127 30 72
QUETIAPINE FUMARATE 132 90 31 77
TAMSULOSIN HCL 129 123 32 26
MEGESTROL ACETATE 127 121 R 33 138
SPIRONOLACTONE 122 94 34 53
COMBIVENT 117 68 35 123
ATENOLOL 115 115 36 18
LANTUS 115 87 36 55
ISOSORBIDE MONONITRATE ER 114 95 38 50
PHENYTOIN SODIUM EXTENDED 113 73 39 103
CLONIDINE HCL 107 93 40 35
DIOVAN 103 67 41 38
NOVOLOG 100 79 42 106
ESCITALOPRAM OXALATE 98 86 43 56
PREDNISONE 93 67 44 42
POLYETHYLENE GLYCOL 3350 91 84 45 67
NEXIUM 89 65 46 23
METHYLPREDNISOLONE 89 42 46 118
FAMOTIDINE 87 67 48 59
IPRATROPIUM-ALBUTEROL 85 84 49 155
HYDROCHLOROTHIAZIDE 83 57 50 13
BENAZEPRIL HCL 81 58 51 80
SERTRALINE HCL 76 62 52 27
LYRICA 76 57 52 66
RAMIPRIL 75 65 54 71
DIOVAN HCT 72 53 55 65
LEVOFLOXACIN 71 51 56 79
PROMETHAZINE HCL 68 30 R 57 85
PANTOPRAZOLE SODIUM 68 57 57 62
DIGOXIN 66 57 59 44
LANTUS SOLOSTAR 64 33 60 109
SEROQUEL 63 47 61 149
CRESTOR 60 60 62 34
LOVASTATIN 58 46 63 39
MIRTAZAPINE 58 51 63 58
TRAZODONE HCL 58 41 63 31
LEVETIRACETAM 58 45 63 131
METOCLOPRAMIDE HCL 57 53 67 110
VERAPAMIL ER 57 53 67 83
SPIRIVA 56 55 69 68
GLYBURIDE-METFORMIN HCL 56 35 R 69 82
ADVAIR DISKUS 54 40 71 63
SYNTHROID 54 41 71 47
LIPITOR 54 44 71 112
PEN NEEDLE 51 34 74 140
RISPERIDONE 50 32 75 81
INSULIN SYRINGE 50 28 75 93
SPS 50 50 75 355
FLUTICASONE PROPIONATE 50 28 75 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.